The European Journal of Health Economics

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers.

Create citation feed for this series

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.18 0 0 0 0.08 1997 0.22 0 0 0 0.09 1998 0.25 0 0 0 0.1 1999 0.31 0 0 0 0.15 2000 0.42 0 0 0 0.19 2001 0.41 0 0 0 0.16 2002 0.44 0 0 0 0.2 2003 0.46 0 0 0 0.21 2004 0.51 0 0 0 0.23 2005 0.54 0 0 0 0.24 2006 0.56 54 28 0 0 1 0.02 0.24 2007 0.17 0.45 46 12 54 9 22.2 2 0.04 0.21 2008 0.1 0.5 57 8 100 10 20 1 0.02 0.24
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:	Immediacy Index:
Documents published:	Citations received:

Most cited documents in this series:

(1) RePEc:spr:eujhec:v:7:y:2006:i:1:p:7-18 The relationship between health care expenditure and health outcomes (2006).
Cited: 9 times.

(2) RePEc:spr:eujhec:v:8:y:2007:i:1:p:31-39 Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set (2007).
Cited: 4 times.

(3) RePEc:spr:eujhec:v:8:y:2007:i:3:p:195-212 Risk adjustment policy options for casemix funding: international lessons in financing reform (2007).
Cited: 4 times.

(4) RePEc:spr:eujhec:v:7:y:2006:i:3:p:212-217 Alcohol-related mortality, drinking behavior, and business cycles (2006).
Cited: 3 times.

(5) RePEc:spr:eujhec:v:7:y:2006:i:1:p:37-45 Fixed budgets as a cost containment measure for pharmaceuticals (2006).
Cited: 3 times.

(6) RePEc:spr:eujhec:v:7:y:2006:i:2:p:114-116 Health care and patients’ migration across Spanish regions (2006).
Cited: 3 times.

(7) RePEc:spr:eujhec:v:7:y:2006:i:4:p:223-224 Time for a common standard for cost-effectiveness in Europe? (2006).
Cited: 2 times.

(8) RePEc:spr:eujhec:v:7:y:2006:i:3:p:204-211 Price regulation and generic competition in the pharmaceutical market (2006).
Cited: 2 times.

(9) RePEc:spr:eujhec:v:7:y:2006:i:4:p:285-289 Tests of stationarity and cointegration of health care expenditure and gross domestic product (2006).
Cited: 2 times.

(10) RePEc:spr:eujhec:v:10:y:2009:i:2:p:207-215 Quality choice in a health care market: a mixed duopoly approach (2009).
Cited: 1 times.

(11) RePEc:spr:eujhec:v:9:y:2008:i:2:p:127-136 The search for good compliance: economic aspects of a conveyed combination pharmaco-therapy, exemplified by an osteoporosis therapy (2008).
Cited: 1 times.

(12) RePEc:spr:eujhec:v:8:y:2007:i:3:p:213-223 Incorporating efficiency in hospital-capacity planning in Germany (2007).
Cited: 1 times.

(13) RePEc:spr:eujhec:v:9:y:2008:i:1:p:5-29 Procedures and methods of benefit assessments for medicines in Germany (2008).
Cited: 1 times.

(14) RePEc:spr:eujhec:v:11:y:2010:i:4:p:355-365 ().
Cited: 1 times.

(15) RePEc:spr:eujhec:v:8:y:2007:i:2:p:105-110 Patients’ willingness to pay for electronic communication with their general practitioner (2007).
Cited: 1 times.

(16) RePEc:spr:eujhec:v:7:y:2006:i:3:p:165-172 A decision model to compare health care costs of olanzapine and risperidone treatment for schizophrenia in Germany (2006).
Cited: 1 times.

(17) RePEc:spr:eujhec:v:8:y:2008:i:2:p:49-60 The burden of rheumatoid arthritis and access to treatment: health burden and costs (2008).
Cited: 1 times.

(18) RePEc:spr:eujhec:v:10:y:2010:i:1:p:35-40 The disease burden of colorectal cancer in Hungary (2010).
Cited: 1 times.

(19) RePEc:spr:eujhec:v:9:y:2008:i:4:p:361-367 Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France (2008).
Cited: 1 times.

(20) RePEc:spr:eujhec:v:7:y:2006:i:2:p:91-98 The reasons of general practitioners for promoting colorectal cancer mass screening in France (2006).
Cited: 1 times.

(21) RePEc:spr:eujhec:v:8:y:2007:i:3:p:297-300 Economic aspects of the new Spanish laws on pharmaceutical preparations (2007).
Cited: 1 times.

(22) RePEc:spr:eujhec:v:10:y:2009:i:2:p:227-231 Factors affecting nurses’ decision to get the flu vaccine (2009).
Cited: 1 times.

(23) RePEc:spr:eujhec:v:9:y:2008:i:2:p:157-163 Eligibility for free GP care, “need” and GP visiting in Ireland (2008).
Cited: 1 times.

(24) RePEc:spr:eujhec:v:7:y:2006:i:1:p:79-83 Off-patent drugs in Italy (2006).
Cited: 1 times.

(25) RePEc:spr:eujhec:v:8:y:2007:i:3:p:225-236 Variations in activity and practice patterns: a French study for GPs (2007).
Cited: 1 times.

(26) RePEc:spr:eujhec:v:9:y:2008:i:1:p:69-78 Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone (2008).
Cited: 1 times.

(27) RePEc:spr:eujhec:v:7:y:2006:i:3:p:195-203 Determinants of household health expenditure on western institutional health care (2006).
Cited: 1 times.

(28) RePEc:spr:eujhec:v:8:y:2008:i:2:p:95-106 The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments (2008).
Cited: 1 times.

(29) RePEc:spr:eujhec:v:11:y:2010:i:3:p:255-266 The impact of missing data in the estimation of concentration index: a potential source of bias (2010).
Cited: 1 times.

(30) RePEc:spr:eujhec:v:8:y:2007:i:1:p:59-65 A multilevel analysis on the determinants of regional health care expenditure: a note (2007).
Cited: 1 times.

(31) RePEc:spr:eujhec:v:9:y:2008:i:4:p:405-416 Redistributive effects in public health care financing (2008).
Cited: 1 times.

(32) RePEc:spr:eujhec:v:7:y:2006:i:2:p:99-106 Choices and utilization in dental care (2006).
Cited: 1 times.

(33) RePEc:spr:eujhec:v:8:y:2007:i:4:p:305-312 Foreign direct investment in the health care sector and most-favoured locations in developing countries (2007).
Cited: 1 times.

(34) RePEc:spr:eujhec:v:10:y:2009:i:4:p:371-388 Can Mediterranean diet really influence obesity? Evidence from propensity score matching (2009).
Cited: 1 times.

(35) RePEc:spr:eujhec:v:8:y:2007:i:1:p:1-3 Should we really worry about “launch delays” of new drugs in OECD countries? (2007).
Cited: 1 times.

(36) RePEc:spr:eujhec:v:9:y:2008:i:3:p:205-207 IQWiG: an opportunity lost? (2008).
Cited: 1 times.

(37) RePEc:spr:eujhec:v:8:y:2007:i:3:p:253-266 Patient access to pharmaceuticals: an international comparison (2007).
Cited: 1 times.

Recent citations received in: | 2008 | 2007 | 2006 | 2005

Recent citations received in: 2008

(1) RePEc:pra:mprapa:8280 Improving prevention compliance through appropriate incentives (2008). University Library of Munich, Germany / MPRA Paper

Recent citations received in: 2007

(1) RePEc:jns:jbstat:v:227:y:2007:i:5-6:p:485-501 Theorie und Praxis des Risikostrukturausgleichs (2007). Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik)

(2) RePEc:spr:eujhec:v:8:y:2007:i:2:p:169-170 Comment on: Should we really worry about “launch delays” of new drugs in OECD countries? by L. Garatinni and S. Ghislandi (2007). The European Journal of Health Economics

Recent citations received in: 2006

(1) RePEc:spr:eujhec:v:7:y:2006:i:3:p:218-220 Decision models in the evaluation of psychotropic drugs (2006). The European Journal of Health Economics

Recent citations received in: 2005

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.